Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Krista McCutcheon"'
Autor:
Tao Huang, An Song, Ryan Stafford, Maria Jose Costa, Jing-Tyan Ma, Krista McCutcheon, Heyu Chen, Kyu Hong, Ningyan Zhang, Zhiqiang An, Cheng Cheng Zhang, X Charlene Liao, Caroline Bonnans, Azita Tabrizi, Jingjing Xie, Hongyu Tian, Xun Gui
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/32c0a8d9110944f2aca679ae4d4aa3f6
Autor:
Tao Huang, An Song, Ryan Stafford, Maria Jose Costa, Zhiqiang Ku, Jing-Tyan Ma, Krista McCutcheon, Xiaoye Liu, Heyu Chen, Kyu Hong, Ningyan Zhang, Zhiqiang An, Cheng Cheng Zhang, X Charlene Liao
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/bb1d0a2138c845c9b062f11fd56be607
Autor:
Paul Polakis, Ron Firestein, Janet Tien, Elizabeth Luis, Suzanna Clark, Ronald Ferrando, Krista McCutcheon, Jennifer Arca, Chae Reed, Jyoti Asundi
Purpose: To identify and evaluate targets amenable to antibody therapy in melanoma.Experimental Design: We searched for mRNA transcripts coding for cell-surface proteins with expression patterns similar to that of the melanoma oncogene MITF. One such
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::287297537d2b83e738082900fe50289d
https://doi.org/10.1158/1078-0432.c.6520098.v1
https://doi.org/10.1158/1078-0432.c.6520098.v1
Autor:
Paul Polakis, Ron Firestein, Janet Tien, Elizabeth Luis, Suzanna Clark, Ronald Ferrando, Krista McCutcheon, Jennifer Arca, Chae Reed, Jyoti Asundi
Supplementary Figures S1-S6.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::291903fc524e9d05cfc2729d220ed95d
https://doi.org/10.1158/1078-0432.22444209
https://doi.org/10.1158/1078-0432.22444209
Autor:
Tao Huang, Kyu Hong, Krista McCutcheon, Jing-Tyan Ma, Ying Zhu, Mi Deng, Cheng Cheng Zhang, Paul Woodard, Hong Xiang, Xiao Min Schebye, X. Charlene Liao
Publikováno v:
Cancer Research. 83:LB217-LB217
Background: Acute myeloid leukemia (AML) remains one of the highest unmet needs among human cancers. LILRB4 is specifically expressed on M4 myelomonocytic and M5 monocytic AML cells with a lack of expression on normal hematopoietic stem cells and pro
Autor:
X. Charlene Liao, Azita Tabrizi, Jing-Tyan Ma, Heyu Chen, Caroline Bonnans, Krista McCutcheon, Cheng Cheng Zhang, Jingjing Xie, Ningyan Zhang, Zhiqiang An, An Song, Marco Costa, Hongyu Tian, Tao Huang, Xun Gui, Kyu Hong, Ryan Stafford
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundThe Leukocyte Associated Immunoglobulin-like Receptor 1 (LAIR1) is an immune inhibitory transmembrane glycoprotein expressed on lymphocytes and myeloid cells. The known ligands for LAIR1 are proteins containing collagen-like domains includi
Autor:
Jing-Tyan Ma, Xiaoye Liu, Ryan Stafford, Krista McCutcheon, Heyu Chen, Tao Huang, Hongyu Tian, Kyu Hong, ChengCheng Zhang, Luke Chung, An Song, Paul Woodard, XCharlene Liao, MariaJose Costa
Publikováno v:
Cancer Research. 82:601-601
Tumor-associated myeloid cells inhibit anti-cancer immune responses systemically and in the tumor microenvironment (TME), thereby limiting the efficacy of T cell checkpoint inhibitors. However, the plasticity of myeloid cells may enable therapeutic i
Autor:
Zhiqiang Ku, Heyu Chen, Krista McCutcheon, An Song, Ningyan Zhang, Xiaoye Liu, Kyu Hong, X. Charlene Liao, Ryan Stafford, Tao Huang, Marco Costa, Cheng Cheng Zhang, Jing-Tyan Ma, Zhiqiang An
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Background Myeloid-derived suppressor cells and tumor-associated macrophages inhibit anti-cancer immune responses systemically and in the tumor microenvironment, respectively, thereby limiting the efficacy of immune checkpoint blockers.1–5 However,
Autor:
George Stepan, Shekeba Ahmadyar, Michel Perron, Brian E. Schultz, Helen Yu, Ona Barauskas, Roman Sakowicz, Yili Xu, Yeojin Park, Jason K. Perry, Joy Y. Feng, Adrian S. Ray, Krista McCutcheon, Darius Babusis
Publikováno v:
Antimicrobial Agents and Chemotherapy
Toxicity has emerged during the clinical development of many but not all nucleotide inhibitors (NI) of hepatitis C virus (HCV). To better understand the mechanism for adverse events, clinically relevant HCV NI were characterized in biochemical and ce
Autor:
Anat Yanai, Blair R. Leavitt, Cheryl L. Wellington, Shinji Hadano, Roshni R. Singaraja, Vikramjit Chopra, Michael R. Hayden, Hong Yi, Joh-E Ikeda, Claire-Anne Gutekunst, Steven M. Hersch, Martina Metzler, Krista McCutcheon, Simon C. Warby, Scott A. Givan, Lu Gan, Jennifer Michel, Keith Fichter
Publikováno v:
Human Molecular Genetics. 11:2815-2828
Huntington disease (HD) is caused by polyglutamine [poly(Q)] expansion in the protein huntingtin (htt). Although the exact mechanism of disease progression remains to be elucidated, altered interactions of mutant htt with its protein partners could c